Zydus Group

Rediff.com » News » Zydus Group

News for Zydus Group

News
Business

Zydus Cadila starts supply of COVID-19 vaccine to govt

Drug firm Zydus Cadila on Wednesday said it has commenced supplies of its COVID-19 vaccine ZyCoV-D to the central government. Photograph: Kind courtesy Zydus Cadila The company has initiated the......

How Covid took devastating turn in 2021

The COVID-19 pandemic took a deadlier and more devastating turn in 2021 soon after a glimmer of hope was provided by the launch of vaccines at the beginning of the year, etching nightmarish......

'Antibodies induced by Covishield and Covaxin gradually increase and decrease'

'Antibodies remain in the blood for at least seven to nine months.' IMAGE: Vaccination on the road at Salamandra village, Margo Munda, in Deoghar, Jharkhand, December 23, 2021. Photograph: ANI......

Only Covaxin available for 15-18-yr-olds, for now

Bharat Biotech's Covaxin is likely to be the only COVID-19 vaccine available, for now, for children in the age group of 15-18 years, who will be inoculated from January 3, official sources said.......

Covaxin gets nod for use in children above 12 years with riders

The Drugs Controller General of India (DCGI) has granted emergency use authorisation to indigenously-developed Bharat Biotech's Covaxin for children above 12 years with certain conditions, official......

Inflation a cause of worry for FMCG companies; margins could take a hit

While companies remain cautiously optimistic about demand panning out this year, a dry August has already played spoilsport for demand, especially in rural areas. Higher inflation has again become......

2 major factors that will weigh on demand and margins of FMCG

Irregular rainfall and a pick-up in commodity costs are expected to weigh on the demand and margins of fast-moving consumer goods (FMCG) companies. Photograph: Mansi Thapliya/Reuters Most......

Pharma stocks rally on lower price erosion, hopes of US generic mkt uptick

Healthcare stocks have outperformed the benchmark indices since the start of the current financial year. Illustration: Uttam Ghosh/Rediff.com The BSE Healthcare Index is up 19 per cent as compared......

More than skin-deep: Nifty Next 50 complexion to get a shade of difference

The National Stock Exchange (NSE) Nifty Next 50 Index could undergo large-scale changes if the proposed tweaks to its computation methodology get implemented. Photograph: Francis......

How Indian pharma bounced back from lockdown lows

From rising prescriptions to the pharma sales force back on the field with full vigour and companies finally finding their feet with the digital marketing strategies — Indian drug makers have......

Rediff News

Zydus Group

News for Zydus Group

Zydus Cadila starts supply of COVID-19 vaccine to govt

How Covid took devastating turn in 2021

'Antibodies induced by Covishield and Covaxin gradually increase and decrease'

Only Covaxin available for 15-18-yr-olds, for now

Covaxin gets nod for use in children above 12 years with riders

Inflation a cause of worry for FMCG companies; margins could take a hit

2 major factors that will weigh on demand and margins of FMCG

Pharma stocks rally on lower price erosion, hopes of US generic mkt uptick

More than skin-deep: Nifty Next 50 complexion to get a shade of difference

How Indian pharma bounced back from lockdown lows

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS